Compulsive use of alcohol has been hypothesized to be driven by multiple sources of reinforcement that change with the individual's transition from social drinking to abuse and substance dependence on alcohol. The overarching hypothesis behind the present project is that understanding the dysregulations of the gene regulatory network that underlie the neuroadaptive changes associated with alcohol dependence will allow the identification of new and more effective therapeutic targets for alcohol abuse. Specifically, the goal of the present study is to use a state of the art systems biology strategy in conjunction with a validated rat model of dependence-induced escalated drinking and laser microdissection to reconstruct a Central Nervous System interactome (CNSi). The CNSi will integrate multiple levels of gene expression regulation including the transcriptional (mRNA), post-transcriptional (miRNA) and post-translational (protein-protein interactions and modulators of transcription factor activity) levels. The CNSi will be used to identify the master regulator genes (MRs) that activate specific gene signatures associated with the transition from moderate to excessive alcohol intake associated with dependence in brain regions of the reward and stress systems. The present multiple principal investigator (MPI) project will involve 2 components: 1) The Scripps Research Institute (TSRI) component will carry out the animal models and laser microdissections of brain regions relevant to the reward and stress systems;2) the Columbia University (CU) component will execute the systems biology strategy. It is expected that the identification of MRs of excessive alcohol intake and modulators of their activity will inform new therapeutic strategies and candidate druggable targets.
The proposed study is aimed at dissecting molecular interactions involved in the transition from social drinking to excessive drinking and substance dependence on alcohol using a recently introduced systems biology strategy in conjunction with RNA-Seq, laser microdissections, and an established rat model of dependence-induced excessive drinking. The present computational-experimental approach will highlight the gene signatures associated with excessive drinking and the master regulator genes that regulate their expression. The results of the study will highlight new pathogenic mechanisms and therapeutic strategies for treatment and prevention of alcohol abuse.
|Sanna, Pietro Paolo; Repunte-Canonigo, Vez; Masliah, Eliezer et al. (2017) Gene expression patterns associated with neurological disease in human HIV infection. PLoS One 12:e0175316|
|Sanna, P P; Kawamura, T; Chen, J et al. (2016) 11?-hydroxysteroid dehydrogenase inhibition as a new potential therapeutic target for alcohol abuse. Transl Psychiatry 6:e760|
|Farris, Sean P; Pietrzykowski, Andrzej Z; Miles, Michael F et al. (2015) Applying the new genomics to alcohol dependence. Alcohol 49:825-36|
|Repunte-Canonigo, Vez; Herman, Melissa; Kawamura, Tomoya et al. (2015) Nf1 regulates alcohol dependence-associated excessive drinking and gamma-aminobutyric acid release in the central amygdala in mice and is associated with alcohol dependence in humans. Biol Psychiatry 77:870-879|
|Repunte-Canonigo, Vez; Shin, William; Vendruscolo, Leandro F et al. (2015) Identifying candidate drivers of alcohol dependence-induced excessive drinking by assembly and interrogation of brain-specific regulatory networks. Genome Biol 16:68|
|Repunte-Canonigo, Vez; Chen, Jihuan; Lefebvre, Celine et al. (2014) MeCP2 regulates ethanol sensitivity and intake. Addict Biol 19:791-9|
|Repunte-Canonigo, Vez; Lefebvre, Celine; George, Olivier et al. (2014) Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Mol Neurodegener 9:26|
|Grieder, Taryn E; Herman, Melissa A; Contet, Candice et al. (2014) VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation. Nat Neurosci 17:1751-8|
|Chen, Jihuan; Repunte-Canonigo, Vez; Kawamura, Tomoya et al. (2013) Hypothalamic proteoglycan syndecan-3 is a novel cocaine addiction resilience factor. Nat Commun 4:1955|